https://pubmed.ncbi.nlm.nih.gov/42011212/
Development and validation of a customised PRO-CTCAE scale for adult-type diffuse gliomas...
Beijing Medical Award Foundation; Shanghai Municipal Health Commission; Department of Science and Technology of Ningxia Hui Autonomous Region; Huashan...
https://healthcaredelivery.cancer.gov/pro-ctcae/
Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
PRO-CTCAE is a patient-reported outcome (PRO) measurement system developed to evaluate symptomatic toxicity in patients on cancer clinical trials.
patient reported outcomes